Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
25.6M
-
Shares change
-
-5.39M
-
Total reported value, excl. options
-
$14.5M
-
Value change
-
-$7.42M
-
Put/Call ratio
-
0.23
-
Number of buys
-
30
-
Number of sells
-
-49
-
Price
-
$0.57
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q1 2025
103 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q1 2025.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.6M shares
of 44.7M outstanding shares and own 57.4% of the company stock.
Largest 10 shareholders include AMH Equity Ltd (3.39M shares), BlackRock, Inc. (2.82M shares), Harvey Partners, LLC (2.19M shares), VANGUARD GROUP INC (2.14M shares), ROYCE & ASSOCIATES LP (1.78M shares), Granahan Investment Management, LLC (1.53M shares), DIMENSIONAL FUND ADVISORS LP (1.44M shares), HEARTLAND ADVISORS INC (1.11M shares), ACADIAN ASSET MANAGEMENT LLC (1.08M shares), and GEODE CAPITAL MANAGEMENT, LLC (923K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.